ESC 365 - Tafamidis for cardiac amyloidosis.

ESC Premium Access

Tafamidis for cardiac amyloidosis.

Session: Success stories in translation from bench to bedside

Topic: Drugs, Drug Targets

Speaker: Professor C. Rapezzi (Ferrara, IT)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)

29 presentations

2 followers

3 more presentations in this session

PCSK9 inhibition for cholesterol lowering.

Speaker: Professor C. Boileau (Paris, FR)

Prolactin for peripartum cardiomyopathy.

Speaker: Professor D. Hilfiker-Kleiner (Hannover, DE)

sGLTII inhibitors for heart failure .

Speaker: Doctor G. Lopaschuk (Edmonton, CA)

Access the full session

Success stories in translation from bench to bedside

Speakers: Professor C. Rapezzi, Professor C. Boileau, Professor D. Hilfiker-Kleiner, Doctor G. Lopaschuk

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by